Better Understanding of HIV Infection and AIDS may be Possible Thanks to IRCM Researchers

by Kathy Jones on  September 03, 2010 at 10:55 PM AIDS/HIV News
  •   Print
  •   Share
  •   Comments
  •  Text 
The results of the most recent research on the role of the Vpr protein in HIV infection and AIDS has been published by Dr. Éric A. Cohen, Director of the Human Retrovirology research unit at the Institut de recherches cliniques de Montréal (IRCM), and his team in the online open-access journal PLos Pathogens.

"We previously identified that HIV, when infecting target cells, blocks cell division and induces cell death," says Dr. Cohen. "We then discovered that the Vpr protein was involved in this process."

HIV-1 encodes several proteins, including the viral protein R (Vpr), which plays an important role in the development of acquired immunodeficiency syndrome (AIDS). Vpr blocks normal cell division, a process believed to increase viral replication and to trigger immune cell death. The researchers recently showed that Vpr performs this activity by interacting with a cellular protein complex (E3 ligase) involved in ubiquitination. Ubiquitination is characterized by the conjugation of a small protein called ubiquitin to various other proteins to regulate their degradation or activities. They also demonstrated that Vpr engages this protein complex to ubiquitinate a yet to be discovered host factor, whose degradation triggers the arrest of cell division.

"We understand the process, but we still don't know which cellular factor is targeted by Vpr to block cell division and where these events are occurring within the infected cell," explains Dr. Jean-Phillippe Belzile, a postdoctoral fellow in Dr. Cohen's research unit and first author of the article. "If we can identify this unknown host factor and determine its role in the cell cycle, it will undoubtedly have an impact on our understanding of HIV infection and the processes of immune cell death that characterize AIDS. We believe that the identification of this host factor could, in the long run, lead us to new potential therapeutic targets."

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
AIDS
Complete Medindia Resources
News Categories:  
Obesity Health Center

AIDS/HIV Related News

» Antibodies That Help to Stop HIV Virus Found in Breast Milk » Rectal Use of Reduced Glycerin Formulation of Tenofovir Vaginal Gel Deemed Safe
» Report Says Clergy can Fight HIV on Faith-Friendly Terms » HIV Epidemic may Afflict Nearly Half of Asia-Pacific Transgender People: UN
» 740,000 Lives Rescued With US AIDS Relief Program: Study » Include Behavioural Strategies in HIV Prevention Measures To Function: APA
» US Panel Urges Quick In-home HIV Test Approval » Funding Criminal Justice Reforms Key to Reducing Spread of HIV and TB in African Prisons
Read More >>